Online citations, reference lists, and bibliographies.
← Back to Search

Insulin Therapies - Past, Present And Future.

O. Pillai, R. Panchagnula
Published 2001 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The discovery of insulin is one of the greatest milestones in medical history. This discovery revolutionized the use of peptides and proteins as therapeutic agents. For more than six decades, insulin from different animal sources was used, until the breakthrough in biotechnology made it possible to produce human insulin in sufficient amounts. The evolution of the biotechnological era gave rise to modified insulins to solve some of the bottlenecks in insulin therapy. Efforts are currently focused towards developing non-invasive insulin delivery systems, and there are several competing technologies in different stages of development. The next few years will see several novel approaches to mimic the endogenous release and kinetics of insulin, and also many improved analogues designed to achieve better control and effective treatment of diabetes.
This paper references
10.2337/diacare.18.3.388
Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study
H. Hanaire-Broutin (1995)
10.1021/JS980042+
Microfabricated microneedles: a novel approach to transdermal drug delivery.
S. Henry (1998)
10.1016/S0169-409X(98)00019-2
Development of engineered pancreatic β-cell lines for cell therapy of diabetes
S. Efrat (1998)
Oral insulin delivery1
Gerardo Carino (1999)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.1007/978-94-011-2734-9
Diabetes and Atherosclerosis
R. W. Stout (1992)
10.1038/nm1195-1132
A sweeter life for diabetics?
R. H. Guy (1995)
10.1016/S1367-5931(00)00111-3
Transdermal iontophoresis revisited.
R. Panchagnula (2000)
10.1126/SCIENCE.291.5507.1224
Dissecting Human Disease in the Postgenomic Era
L. Peltonen (2001)
10.1016/S1359-6446(00)01580-4
Quo vadis, biotech? (Part 1).
Drews (2000)
10.1016/S0140-6736(99)90034-X
Implantable insulin pumps
Jl Selam (1999)
10.3810/PGM.1997.02.157
Insulin analogues: new agents for improving glycemic control.
J. White (1997)
10.1021/CR000700M
Peroral route: an opportunity for protein and peptide drug delivery.
A. Sood (2001)
10.2165/00003088-199733040-00004
Pharmacokinetic Considerations of New Insulin Formulations and Routes of Administration
A. Hoffman (1997)
10.3109/03639049809082359
Recent approaches in insulin delivery.
A. Trehan (1998)
10.1038/35044106
Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue
H. Lee (2000)
10.1126/SCIENCE.284.5416.974
Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.
B. Zhang (1999)
THE PHARMACOLOGICAL AND TOXIC ACTION OF DIGOXIN
A. White (1934)
10.1016/S0378-5173(97)00237-8
Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract
K. Iwanaga (1997)
10.1016/S1043-2760(98)00083-6
Lispro Insulin: Benefits and Limitations
M. Burge (1998)
10.1016/S0168-3659(96)01578-7
Insulin and the gastrointestinal tract
M. Saffran (1997)
10.2337/diab.23.5.397
Clinical Control of Diabetes by the Artificial Pancreas
A. Albisser (1974)
10.1073/PNAS.12.2.132
Crystalline Insulin.
J. J. Abel (1926)
10.1126/SCIENCE.3526553
A new approach to the oral administration of insulin and other peptide drugs.
M. Saffran (1986)
INSULIN TO HUMAN INSULIN
M. Sumra (1995)
Rectal administration of insulin.
R. Wa (1984)
10.1073/PNAS.76.1.106
Expression in Escherichia coli of chemically synthesized genes for human insulin.
D. Goeddel (1979)
10.1016/S0169-409X(98)00072-6
Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment.
Jeandidier (1999)
10.2337/diacare.13.9.923
Monomeric Insulins and Their Experimental and Clinical Implications
J. Brange (1990)
10.5551/JAT1973.14.1_1
Insulin and atherosclerosis
R. Stout (1986)
10.1126/SCIENCE.116.3015.394
Crystalline and amorphous insulin-zinc compounds with prolonged action.
K. Hallas-Møller (1952)
10.1002/1521-3773(20000717)39:14<2396::AID-ANIE2396>3.0.CO;2-U
Microchips as Controlled Drug-Delivery Devices.
J. T. Santini (2000)
10.1038/224491A0
Structure of Rhombohedral 2 Zinc Insulin Crystals
M. Adams (1969)
10.2337/DIACARE.22.5.801
Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.
A. Lindholm (1999)
Controlled drug delivery in the treatment of diabetes mellitus.
K. Irsigler (1985)
10.2337/diab.28.7.634
Control of Blood Glucose in Experimental Diabetes by Means of a Totally Implantable Insulin Infusion Device
P. Blackshear (1979)
10.1056/NEJM198908103210605
The Physiologic Replacement of Insulin
B. Zinman (1989)
10.3810/PGM.1999.10.15.751
Insulin delivery using pen devices. Simple-to-use tools may help young and old alike.
N. Bohannon (1999)
10.2165/00003495-198224050-00003
The New Insulins
P. D. Home (2012)
10.1016/S0169-409X(98)00079-9
Insulin analogs with improved pharmacokinetic profiles.
Brange (1999)
Tennis anyone? The lungs as a new court for systemic therapy.
M. Newhouse (1999)
10.2337/diab.41.6.657
Why Intraperitoneal Delivery of Insulin With Implantable Pumps in NIDDM?
W. Duckworth (1992)
10.1002/j.1550-8528.1996.tb00274.x
Immunoassay of endogenous plasma insulin in man.
R. Yalow (1960)
A permanently implantable self-recycling low flow constant rate multipurpose infusion pump of simple design.
P. Blackshear (1970)
10.1016/S1357-4310(98)01425-7
Towards gene therapy of diabetes mellitus.
F. Levine (1999)
10.1016/S0168-3659(97)00258-7
Extracellular matrix for a rechargeable cell delivery system.
Y. Bae (1998)
10.1126/SCIENCE.129.3359.1340
Chemistry of insulin; determination of the structure of insulin opens the way to greater understanding of life processes.
F. Sanger (1959)
10.1056/NEJM199309303291401
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group.
P. Saenger (1993)
10.2337/diab.46.4.637
Acylation of Human Insulin With Palmitic Acid Extends the Time Action of Human Insulin in Diabetic Dogs
S. Myers (1997)
10.1016/S0169-409X(00)00136-8
Responsive polymeric delivery systems.
J. Kost (2001)
10.1126/SCIENCE.287.5454.826
Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum.
V. Rivera (2000)
10.1126/SCIENCE.287.5460.1960
Drug discovery: a historical perspective.
J. Drews (2000)
10.1016/S1367-5931(00)00226-X
Drug delivery: an odyssey of 100 years.
O. Pillai (2001)



This paper is referenced by
10.1016/B978-0-323-52725-5.00006-X
Nanometric Biopolymer Devices for Oral Delivery of Macromolecules with Clinical Significance
Sabyasachi Maiti (2017)
10.2174/187221109787158346
Chitosan and its use in design of insulin delivery system.
T. Wong (2009)
10.1023/B:PHAM.0000048195.69304.ff
Formulating Insulin for Oral Administration: Preparation of Hyaluronan-Insulin Complex
Gustaf Jederstrom (2004)
10.1016/j.addr.2011.10.006
Oral colon delivery of insulin with the aid of functional adjuvants.
A. Maroni (2012)
10.1002/JPS.20969
Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin.
Udhumansha Ubaidulla (2007)
10.1016/j.domaniend.2013.01.006
Evaluation of a high-yield technique for pancreatic islet isolation from deceased canine donors.
D. Vrabelova (2014)
10.1016/J.PHYTOL.2008.09.001
Reappraising a decade old explanatory model for pharmacognosy
Sonny Larsson (2008)
10.1016/j.regpep.2009.06.001
Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain
L. Yong (2009)
10.3390/ijms18010054
Multifunctional Composite Microcapsules for Oral Delivery of Insulin
S. Sun (2016)
10.1007/s00253-004-1809-x
Therapeutic insulins and their large-scale manufacture
G. Walsh (2004)
10.1016/S0378-5173(02)00149-7
Microencapsulation of protein particles within lipids using a novel supercritical fluid process.
I. Ribeiro Dos Santos (2002)
10.1016/j.ijpharm.2011.12.017
Polyelectrolyte complex nanoparticles of amino poly(glycerol methacrylate)s and insulin.
Xueyou Lu (2012)
10.1016/J.CARBPOL.2011.04.070
Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for oral insulin delivery
Kok Hoong Leong (2011)
10.1089/DIA.2005.7.948
Blood glucose-lowering activity of a hyaluronan-insulin complex after oral administration to rats with diabetes.
Gustaf Jederström (2005)
10.1016/j.ejpb.2010.07.002
Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats.
G. Sharma (2010)
10.1208/s12249-014-0282-9
Development of Acid-Resistant Alginate/Trimethyl Chitosan Nanoparticles Containing Cationic β-Cyclodextrin Polymers for Insulin Oral Delivery
Maryam Mansourpour (2014)
10.1111/j.1365-2710.2007.00835.x
Comparing two botulinum toxin type A formulations using manufacturers’ product summaries
R. Wenzel (2007)
Protein stability in shear flow
Innocent B. Bekard (2010)
10.1208/pt060227
Nasal insulin gel as an alternate to parenteral insulin: Formulation, preclinical, and clinical studies
R. D'souza (2008)
10.1002/anie.200801367
Functionalizing glycine derivatives by direct C-C bond formation.
L. Zhao (2008)
10.1089/dia.2009.0176
Pharmacokinetic and pharmacodynamic evaluation of insulin dissolving microneedles in dogs.
K. Fukushima (2010)
10.1016/j.ijpharm.2015.06.013
Complexation of cationic-neutral block polyelectrolyte with insulin and in vitro release studies.
N. Pippa (2015)
10.1080/09205063.2015.1111718
Release profile of insulin from pH-sensitive hydrogel and its hypoglycemic effect by oral administration
Yongli Shi (2016)
10.1016/S1359-6446(01)02021-9
Pills and pumps: the future of insulin therapies.
JohnJ Weidner (2001)
10.1016/j.biotechadv.2010.01.005
Production of heterologous proteins in plants: strategies for optimal expression.
P. Desai (2010)
10.1007/978-981-10-8998-5_2
Preparation and Characterization
J. Wu (2018)
10.1248/CPB.56.243
Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs.
Y. Ito (2008)
10.1088/0957-4484/25/34/345102
Recombinant IκBα-loaded curcumin nanoparticles for improved cancer therapeutics.
Subhamoy Banerjee (2014)
10.2147/IJN.S26450
Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin
Shaoping Sun (2011)
10.3109/10611860903302815
Design of oral insulin delivery systems
T. Wong (2010)
The Use of Polyglycol Succinates for the Microencapsulation of Insulin
R. Sariri (2002)
10.1016/j.biomaterials.2014.04.104
Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.
N. Shrestha (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar